drugset
drugset / Trial / NCT07631793

Phase I Clinical Trial of YKYY031 for Injection in Patients With Advanced Solid Tumors

NCT07631793 ↗

Phase 1 Not yet recruiting 76 enrolled Youcare Pharmaceutical Group Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Phase I study of YKYY031 for injection in patients with advanced solid tumors

Timeline

Start
2026-05-30
Primary completion
2027-12-08
Completion
2030-12-07

Drugs

EvaluationDrugModalityDoseRoute
Subject YKYY031 Unknown — Intramuscular

Indications

cancer